Theragent

This page is thin and lacks substantive case-study detail. It states only that Theragent, a CDMO, needed to launch its "state-of-the-art smart manufacturing facility" quickly while maintaining compliance, and that COO Jeff Masten explains why the company adopted "ValGenesis VLMS from day one of operations to achieve and maintain a continuous state of validation." No specific outcomes, metrics, or timeline are given on the page itself — the full case study sits behind a separate "Read Your Case Study" link that was not accessible.

ValGenesis is a digital validation-lifecycle platform — one of the two dominant players, alongside Kneat, in producing the validation evidence a GxP system needs before it can go live.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.